English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Presynaptic pathophysiology encoded in different domains of Tau – hyper- versus hypoexcitability?

Decker, J. M., & Mandelkow, E.-M. (2019). Presynaptic pathophysiology encoded in different domains of Tau – hyper- versus hypoexcitability? In Advances in Experimental Medicine and Biology (pp. 97-103). SpringerNature.

Item is

Files

show Files
hide Files
:
Decker-Mandelkow2019_Chapter_PresynapticPathophysiologyEnco.pdf (Publisher version), 423KB
 
File Permalink:
-
Name:
Decker-Mandelkow2019_Chapter_PresynapticPathophysiologyEnco.pdf
Description:
-
OA-Status:
Visibility:
Restricted (UNKNOWN id 832; )
MIME-Type / Checksum:
application/pdf
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show
hide
Description:
-
OA-Status:

Creators

show
hide
 Creators:
Decker, Jochen M.1, Author
Mandelkow, Eva-Maria1, 2, Author           
Affiliations:
1External Organizations, ou_persistent22              
2Neuronal Cytoskeleton and Alzheimer's Disease, Cooperations, Center of Advanced European Studies and Research (caesar), Max Planck Society, Ludwig-Erhard-Allee 2, 53175 Bonn, DE, ou_2173677              

Content

show
hide
Free keywords: A152T mutation; Hyperexcitability; Hypoexcitability; Network activity; Tauopathy; ΔK280 mutation
 Abstract: Mutations in MAPT (Tau) have been implicated in several types of tauopathy, but the pathways leading to neurodegeneration have remained elusive and are heterogeneous. Here we describe the effects of two mutations, both linked to AD or FTD, that are located in different domains of Tau and show different pathways of toxicity. The deletion mutation ΔK280 lies in the repeat domain and strongly increases β-structure and hence aggregation, whereas the mutation A152T lies in the N-terminal projection domain, has little effect on aggregation but instead on signalling. Both mutations cause presynaptic dysfunction, but in opposite ways, leading to hypoexcitability/hypoactivity vs. hyperexcitability/excitotoxicity, respectively. In organotypic slices these abnormal states can be reversed by drugs, e.g. Tau aggregation inhibitors or modulators of glutamate uptake. This information could contribute to the understanding of “normal” Tau biology and possible therapeutical strategies.

Details

show
hide
Language(s): eng - English
 Dates: 2019
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1007/978-981-32-9358-8_8
PMID: 32096031
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Advances in Experimental Medicine and Biology
  Abbreviation : Adv Exp Med Biol
Source Genre: Series
 Creator(s):
Affiliations:
Publ. Info: SpringerNature
Pages: - Volume / Issue: 1184 Sequence Number: - Start / End Page: 97 - 103 Identifier: ISSN: 0065-2598
CoNE: https://pure.mpg.de/cone/journals/resource/954927588283_1

Source 2

show
hide
Title: Tau Biology
Source Genre: Book
 Creator(s):
Takashima, Akihiko, Editor
Wolozin, Benjamin, Editor
Buee, Luc, Editor
Affiliations:
-
Publ. Info: Singapore : Springer Nature
Pages: - Volume / Issue: - Sequence Number: - Start / End Page: 97 - 103 Identifier: ISBN: 978-981-32-9357-1
DOI: 10.1007/978-981-32-9358-8